How a Pathology LIMS Reduces Turnaround Time — And Why It Matters More Than You Think

A delayed pathology report is never just a delay

When a surgical biopsy result takes eleven days instead of five, a surgeon cannot plan the next intervention. A patient waits — not just for a piece of paper, but for the decision that determines what happens to them next.

Turnaround time (TAT) in pathology is one of the most consequential performance metrics in modern healthcare. It measures the time from specimen receipt to final signed report — and it sits at the intersection of clinical outcomes, patient satisfaction, regulatory compliance, and lab efficiency.

Most pathology labs know their TAT is longer than it should be. Fewer know exactly where the time is being lost — and fewer still have implemented the systematic fix that a modern pathology LIMS makes possible.

This article breaks down where turnaround time is actually lost in a typical pathology lab, and precisely how a well-implemented LIMS recovers it.

Where does turnaround time actually go?

Before discussing the fix, it's worth being precise about the problem. In our experience working with pathology labs across Europe, the Middle East, and India, delays cluster around five recurring bottlenecks — none of which are caused by pathologists being slow. They are caused by systems that were never designed to move information at the speed the workflow demands.

Bottleneck 1 — Accessioning and specimen registration

When a specimen arrives, someone must log it, assign an accession number, attach a label, and route it to the right bench. In labs using manual or semi-manual systems, this step introduces transcription errors, duplicate accession numbers, and — critically — specimens that sit in a queue because no one knows they've arrived.

Bottleneck 2 — Cassette and block tracking

The journey from gross room to embedding to sectioning involves dozens of physical handoffs. A cassette set aside, a block mislabelled, or a sectioning request not communicated — each adds hours. Without a system tracking location and status in real time, supervisors spend significant time simply answering "where is this case?"

Bottleneck 3 — Staining and special study requests

IHC panels, special stains, and ancillary studies are among the most common sources of delay. Requesting a stain on paper or by phone, waiting for confirmation, discovering the reagent is out — each adds a day or more. A lab running ten cases with IHC panels can have 30–40 separate ancillary study requests moving through an informal system at any given time.

Bottleneck 4 — Pathologist assignment and prioritisation

In labs without a LIMS or with a basic LIS, cases land in a pathologist's queue without intelligent prioritisation. An urgent intraoperative consult competes for attention with a routine skin biopsy. A case needing specialist input waits for the generalist to escalate it. Priority is managed by memory and conversation — both of which fail under volume.

Bottleneck 5 — Reporting and sign-off

Dictating a report, waiting for transcription, reviewing the transcription, correcting it, and then signing — this sequence, still common in many labs, adds one to two days to every case.

What a LIMS does to each bottleneck

A modern pathology LIMS doesn't improve turnaround time by making pathologists work faster. It removes the friction that was slowing the entire system down.

At accessioning: Barcode scanning at the point of receipt links the requisition form, patient demographics, and specimen description automatically. Accession numbers are generated without human input. The specimen is visible in the system within seconds of scanning. In high-volume labs, automated accessioning alone typically recovers 20–40 minutes per 100 cases.

In the gross room and processing: The LIMS assigns cassette ranges, prints cassette labels, and records the number of blocks taken — all at the workstation, without paper. When blocks move to the embedding station, the system records the handoff. At any point, a supervisor can open the dashboard and see the exact status of every case in process.

For special studies: Ancillary study requests are placed within the LIMS, routed electronically to the relevant workstation, and tracked against a time-to-completion target. When a reagent lot expires or stock falls below threshold, the system flags it before a pathologist requests the stain — not after.

For pathologist workflow: Cases in a LIMS-driven lab are automatically assigned based on configurable rules — by subspecialty, by workload, by urgency. Intraoperative consultations are flagged automatically and rise to the top of the queue. The pathologist opens a worklist, not an inbox of paper folders.

At reporting and sign-off: Structured report templates — including synoptic cancer reporting formats — allow pathologists to complete reports directly in the LIMS, often within the same session as the diagnosis. Electronic signature replaces dictation, transcription, and review cycles.

What the numbers look like in practice

Pathology labs implementing a modern LIMS with deliberate TAT-reduction goals consistently report similar patterns:

- Gross room to histology: 15–25% reduction through elimination of logging delays and immediate block tracking

- Special study TAT: 30–50% reduction in ancillary study turnaround in volume IHC settings

- Report sign-off: 40–60% reduction in average reporting time vs. dictation-and-transcription workflows

- Overall surgical pathology TAT: 1–3 working days reduction for complex surgical cases

These are not theoretical gains. They are the compound result of eliminating small delays at every stage of a workflow that has dozens of stages.

The hidden cost of long turnaround times

Beyond the clinical impact, long TATs carry a financial and reputational cost that is often underestimated.

Regulatory and accreditation risk: Most accreditation standards (ISO 15189, CAP) specify TAT targets for defined test categories. Consistent failure to meet them is an audit finding — and repeated audit findings jeopardise accreditation. A LIMS with built-in TAT monitoring and automated alerts is the only scalable way to ensure you never discover a systemic delay after the fact.

Staff burden: The time your histotechnologists spend answering "where is case 24681?" is time not spent at the bench. The LIMS dashboard that answers these questions automatically has a measurable impact on staff productivity and satisfaction.

Referral patterns: Clinicians notice TAT. A surgical oncologist who consistently receives reports in four days from your lab and eight days from a competing lab will direct cases accordingly — and will tell colleagues. In markets where lab choice is driven partly by clinician preference, TAT is a competitive factor.

What to look for in a LIMS specifically for TAT reduction

Not every LIMS is built for the operational complexity of reducing turnaround time at scale. When evaluating platforms, look for these specific capabilities:

Real-time specimen tracking dashboard — a live view of every case, its current stage, and its elapsed time against target.

Configurable TAT targets by test type — surgical biopsy, cytology, frozen section, and molecular studies all have different TAT expectations.

Automated priority escalation — urgent cases should surface automatically; the system shouldn't depend on someone remembering to escalate.

Ancillary study integration — the IHC and special stains module must be tightly integrated with the main workflow, not a separate system that requires double entry.

Synoptic reporting templates — structured reporting is the single highest-impact change for sign-off TAT.

TAT analytics — historical TAT data by test type, pathologist, day of week, and workload level.

How SlidePath approaches turnaround time

SlidePath was designed from the ground up for the operational realities of busy pathology labs — not adapted from a generic laboratory solution.

Built-in TAT management includes live specimen tracking across every workflow stage, configurable alert thresholds by case type, automated priority routing, and a management dashboard that gives supervisors a real-time view of the entire lab's case status without requiring a single query or phone call.

The reporting module supports structured synoptic templates, direct electronic sign-off, and HL7/FHIR export to your hospital information system — eliminating the dictation and transcription cycle that accounts for the most recoverable TAT in most labs.

SlidePath is deployed in pathology laboratories across the Middle East, Europe, and India — in environments ranging from single-site hospital labs to multi-centre diagnostic networks — all of which had turnaround time reduction as a primary implementation goal.

Map your TAT bottlenecks — with us

The fastest way to understand where your lab is losing time is to walk through your workflow with someone who has seen the same bottlenecks in dozens of labs.

Book a free TAT workflow review with the SlidePath pathology informatics team. In a 45-minute conversation, we will map your current specimen journey, identify your highest-impact bottlenecks, and show you exactly how SlidePath addresses them — using your workflow, not a generic demo.

No commitment. No generic pitch. A specific conversation about your lab's turnaround time.

Book Your Free Workflow Review → https://www.slidpath.com/demo